Who Owns Xeris Biopharma Stock?
NASDAQ: XERSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:25 PM ET
Ownership breakdown
- Held by institutions
- 60.15%
- Held by insiders
- 3.03%
- Institutional holders
- 311
- Institutions 60.2%
- Insiders 3.0%
- Public and other 36.8%
Who owns Xeris Biopharma stock?
Institutional investors own about 60.2% of Xeris Biopharma's shares, spread across 311 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 3.03% of XERS.
The largest institutional holders are Blackrock Inc. (7.97%), Shaw D.E. & Co., Inc. (4.28%) and Vanguard Capital Management LLC (4.03%). Together, the top 10 institutions control 29.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their XERS positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of XERS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 14.53M | 7.97% | +12.2% |
| Shaw D.E. & Co., Inc. | 7.80M | 4.28% | +0.2% |
| Vanguard Capital Management LLC | 7.34M | 4.03% | +5.2% |
| State Street Corporation | 4.82M | 2.64% | +3.5% |
| Geode Capital Management, LLC | 4.72M | 2.59% | +10.0% |
| Nuveen, LLC | 4.39M | 2.41% | +50.4% |
| Rosalind Advisors, Inc. | 2.91M | 1.60% | -10.0% |
| Qube Research & Technologies Ltd | 2.89M | 1.59% | -29.7% |
| Vanguard Portfolio Management LLC | 2.63M | 1.44% | -1.5% |
| Wellington Management Group, LLP | 2.37M | 1.30% | +8.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of XERS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.19M | 2.85% |
| iShares Trust-iShares Russell 2000 ETF | 4.39M | 2.41% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.99M | 1.09% |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 1.95M | 1.07% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.87M | 1.02% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.59M | 0.87% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 1.20M | 0.66% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 1.03M | 0.56% |
| First TRT Exch-Trd AlphaDEX Fd.-First TRT Small Cap Growth AlphaDEX Fd | 959.28K | 0.53% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 868.76K | 0.48% |
Frequently asked questions
Who is the largest shareholder of Xeris Biopharma?
Blackrock Inc. is the largest institutional shareholder of XERS, owning 7.97% of shares outstanding (14.53M shares) as of its latest 13F filing.
What percentage of Xeris Biopharma is owned by institutions?
Institutions own about 60.2% of XERS shares and 62.0% of the public float.
How much of Xeris Biopharma do insiders own?
Insiders, such as officers and directors, own about 3.03% of XERS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.